The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation-Reference-Cited by-同舟云学术

The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation

Published:2015-04-01 Issue:1 Volume:3 Page:
ISSN:2049-2618
Container-title:Microbiome
language:en
Short-container-title:Microbiome

Author:

Carmody Lisa A,Zhao Jiangchao,Kalikin Linda M,LeBar William,Simon Richard H,Venkataraman Arvind,Schmidt Thomas M,Abdo Zaid,Schloss Patrick D,LiPuma John J

Publisher

Springer Science and Business Media LLC

Subject

Microbiology (medical),Microbiology

Link

http://link.springer.com/content/pdf/10.1186/s40168-015-0074-9.pdf

Reference33 articles.

1. Rogers GB, Carroll MP, Serisier DJ, Hockey PM, Jones G, Bruce KD. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16 s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol. 2004;42:5176–83.

2. Sibley CD, Parkins MD, Rabin HR, Duan K, Norgaard JC, Surette MG. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci U S A. 2008;105:15070–5.

3. Stressmann FA, Rogers GB, Marsh P, Lilley AK, Daniels TW, Carroll MP, et al. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation? J Cyst Fibros. 2011;10:357–65.

4. Tunney MM, Klem ER, Fodor AA, Gilpin DF, Moriarty TF, McGrath SJ, et al. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax. 2011;66:579–84.

5. Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, et al. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. PLoS One. 2012;7:e45001.

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microbiome-Mucosal Immunity Nexus: Driving Forces in Respiratory Disease Progression;Journal of Microbiology;2024-09-06

2. What diagnostic tests are available for respiratory infections or pulmonary exacerbations in cystic fibrosis: A scoping literature review;Respiratory Investigation;2024-09

3. Update on the diagnosis and management of cystic fibrosis pulmonary exacerbations;Journal of Cystic Fibrosis;2024-07

4. Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force;Journal of Cystic Fibrosis;2024-07

5. Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis;Nature Communications;2024-06-07